Oncology (Williston Park, N.Y.)

Journal

Publication Venue For

  • When to order an MRI in the initial evaluation and management of prostate cancer.  32:501-504. 2018
  • Amitkumar Mehta on the Immunomodulating Effects of Targeted Therapy for Multiple Myeloma.  30. 2016
  • Amitkumar Mehta on the immunomodulating effects of targeted therapy for multiple myeloma.  30. 2016
  • Salivary gland cancers: Biology and systemic therapy.  29:773-780. 2015
  • Immune targeting in breast cancer.  29. 2015
  • Immune targeting in breast cancer.  29:375-385. 2015
  • Multimodality therapy for high-risk endometrial cancer: Balancing the courses while keeping all options on the table.  27. 2013
  • Nutrition during and after cancer therapy..  23:15-21. 2009
  • Survivorship care: essential components and models of delivery..  23:46-53. 2009
  • Surgical staging in endometrial cancer.  20:45-50. 2006
  • Woman with a papillary pulmonary lesion and a complex renal cyst.  20. 2006
  • NCCN Practice Guidelines for Cancer-Related Fatigue..  14:151-161. 2000
  • NCCN Practice Guidelines for Acute Myelogenous Leukemia..  14:53-61. 2000
  • NCCN Practice Guidelines for Breast Cancer..  14:33-49. 2000
  • NCCN Practice Guidelines for Cancer-Related Fatigue..  14:151-161. 2000
  • NCCN Practice Guidelines for Chronic Myelogenous Leukemia..  14:229-240. 2000
  • NCCN Practice Guidelines for Head and Neck Cancers..  14:163-194. 2000
  • UFT/oral calcium folinate plus radiation in pancreatic cancer..  13:127-128. 1999
  • NCCN practice guidelines for Hodgkin's disease.  13:78-110. 1999
  • Update: NCCN practice guidelines for the treatment of breast cancer.  13:41-66. 1999
  • QOL and outcomes research in prostate cancer patients with low socioeconomic status..  13. 1999
  • Controversies in the Management of Stage I Seminoma.  12:1203-1212. 1998
  • NGGN Melanoma Practice Guidelines.  12:153-177. 1998
  • Recent Progress in Radioimmunotherapy for Cancer.  11:979-984. 1997
  • New therapeutic options in the management of childhood brain tumors.  6:27-36. 1992
  • Histopathological prognostic factors of certain primary oral cavity cancers..  4:39-45. 1990
  • International Standard Serial Number (issn)

  • 0890-9091
  • Electronic International Standard Serial Number (eissn)

  • 0890-9091